Latest Headlines

  1. Calbiotech And Liquid Biosciences Announce Strategic Collaboration To Accelerate Next-Generation Diagnostic Development 2/10/2026

    Calbiotech, Inc. and Liquid Biosciences today announced a strategic collaboration focused on accelerating the development and commercialization of advanced diagnostic tests across multiple disease areas.

  2. Faster Blood Test Could Support Safer Decision-Making In Drug-Related Emergencies 2/10/2026

    New research from King’s College London suggests that a rapid blood testing method could deliver reliable results far more quickly than previously thought, potentially supporting faster and more accurate decision-making in emergency departments.

  3. From Morphology To Clinical Insights: Ozelle's AI-Powered Diagnostics At WHX Labs Dubai 2026 2/10/2026

    As WHX Labs Dubai 2026 opens today, visitors to Booth S1.D58 are invited to see how Ozelle transforms diagnostic testing into interactive, decision-ready workflows.

  4. Chemspeed And SciY Announce Self Driving Laboratory Platform Integrating Automation, Analytics And AI Orchestration 2/9/2026

    At SLAS2026, Chemspeed Technologies, a leader in the automation and digitalization of R&D and QC laboratories, and SciY, a leader in scientific and laboratory management software focused on lab standardization and AI-readiness, today introduce their open Self‑Driving Lab (SDL) platform.

  5. Opentrons Accelerates The Enablement Of AI-Based Laboratory Robotics With NVIDIA 2/5/2026

    Opentrons Labworks Inc., a laboratory robotics company enabling AI-driven autonomous science, is accelerating the development and deployment of physical AI-enabled laboratory robotics with NVIDIA.

  6. Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers To Cutting-Edge Proactive Care 2/4/2026

    Today, Hims & Hers Health, Inc. the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1.

  7. analytica Conference 2026: From Diagnosing Leukemia To Detecting Opioids 2/4/2026

    Under the motto “Science meets industry”, the analytica conference covers the broad spectrum of analytical chemistry and bioanalytics. From March 24 to 26, researchers from all over the world will present their latest findings in Munich, at the same time as analytica, the world’s leading trade fair for laboratory technology, analysis and biotechnology.​

  8. Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification In Preparation For Manufacturing Upcoming PCR Platform 2/4/2026

    Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara Diagnostics Pvt. Ltd. ("CoSara"), the joint venture between Co-Dx and Ambalal Sarabhai Enterprises Limited (ASE Group), has successfully completed the necessary audits of its quality management system ("QMS") and that its manufacturing facility located in Vadodara, India, has been granted ISO 13485:2016 certification.

  9. Rarity Bioscience Announces That ARUP Laboratories Has Become The First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay 2/3/2026

    Sweden-based Rarity Bioscience today announced that ARUP Laboratories, a leading national reference laboratory and nonprofit enterprise of the University of Utah and its Department of Pathology, has become the first commercial laboratory in the United States to validate and offer its groundbreaking superRCA assay for research applications.

  10. QIAGEN Showcases QIAsprint Connect High-Throughput Automation System For Labs Worldwide At SLAS 2026 2/3/2026

    QIAGEN N.V. today announced the first public showcase of QIAsprint Connect at SLAS 2026 in Boston, marking QIAGEN’s entry into high-throughput benchtop automation for sample processing in research laboratories.